Ghrelin receptor antagonist, JMV 2959 from sigma-aldrich INC:1107546 [17-004516]

Ended Awarded Last action

Contract number
HHSN28100002
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6810 Chemicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$5,390
Original award $5,390

Quick answers

Who was awarded contract HHSN28100002?

HHSN28100002 was awarded to Sigma-Aldrich, Inc. by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on August 24, 2017.

How much is contract HHSN28100002 worth?

The government has obligated $0 on HHSN28100002.

Is contract HHSN28100002 an order under another contract?

Yes. HHSN28100002 is a BPA call under HHSN263201600046B, a blanket purchase agreement.

Was contract HHSN28100002 competed?

The extent of competition for HHSN28100002 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award